Assetmark, Inc Verona Pharma PLC Transaction History

Assetmark, Inc

  • $45.6 Billion
  • Q3 2025

A detailed history of Assetmark, Inc transactions in Verona Pharma PLC stock. As of the latest transaction made, Assetmark, Inc holds 93 shares of VRNA stock, worth $9,942. This represents 0.0% of its overall portfolio holdings.

Number of Shares
93
Previous 93 -0.0%
Holding current value
$9,942
Previous $8,000 12.5%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025
BUY
$28.71 - $47.02 $2,670 - $4,372
93 New
93 $4,000

About Verona Pharma plc

VRNA Quotes by TradingView
  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $6.52B
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email